Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Aleniglipron

A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants

Gasherbrum Bio, Inc · Phase 1 · Status n/r · Enrollment 70

NCT06139055

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.